Annual Report and Form 20-F Information

Overview

The report describes AstraZeneca's return to growth in 2019, with Total Revenue of $24,384 million and a year-end workforce of 70,600 employees. It highlights broad sustainability activity, including Scope 1, Scope 2 and Scope 3 emissions reporting, renewable-energy use, waste and water performance, and the Ambition Zero Carbon strategy. Sustainability disclosures were supported by a structured materiality assessment, GHG Protocol reporting and limited external assurance by Bureau Veritas.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2019
Period: 1 January 2019 – 31 December 2019
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

CDP score

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services

Overview